MARCEVAP

Disease, Cardiovascular Risk and Lifestyle in Primary Care Research Group

This is a multidisciplinary research group in primary care, with a predominantly care profile and the support of professionals with a more methodological profile. The aim of the group is to seek evidence-based answers to the clinical challenges of prevention and care of people with kidney disease and other chronic pathologies, the associated cardiovascular risk, with special attention to the approach to lifestyles. The renal disease line addresses the prevalence, incidence, risk factors, management and associated cardiovascular risk of both mild-moderate chronic kidney disease and advanced disease to prevent progression to end-stage renal disease and its complications. Lifestyle research, in an approach based on prevention and reduction of cardiovascular risk, includes assistance to smokers, promotion of physical activity, nutrition, and the effects of lifestyle on health.

Group projects

R+D+I PROJECTS FUNDED IN COMPETITIVE CALLS FROM ADMINISTRATIONS OR PUBLIC AND PRIVATE ENTITIES

• Premis Sanitat Baix Llobregat 2022. Col·legi Oficial de Metges de Barcelona. IP: Betlem Salvador Gonzalez.

• Malaltia renal crònica (MRC) a Catalunya. Progressió, regressió i tipologia de pacients que reben o no tractament renal substitutiu en insuficiència renal terminal (IRT). ICS - Institut Català de la Salut. 2023 IP: Daniel Bundo Luque.

• GRUP EMERGENT ESTILS DE VIDA. ICS - Institut Català de la Salut. 2021-2023. IP: Laura Illamola Martin.

CONTRACTS, AGREEMENTS OR NON-COMPETITIVE R+D+I PROJECTS WITH ADMINISTRATIONS OR PUBLIC OR PRIVATE ENTITIES.

• App per a mòbils per fer nistagmografíes incorporades a un algoritme diagnòstic del vertigen perifèric paroxistic benigne. NYSTAVERT. Fundació d'Atenció Primària (FAP) - CAMFIC. IP: José Luis Ballvé Moreno.

CLINICAL STUDIES

• Ús de dispositius wearables i aplicacions mòbils de salut (mSalut) per a canviar els estils de vida en Atenció Primària. (BR028). ICS - Institut Català de la Salut. 2022. IP: Francesc Alòs Colomer.

• Sarconut: prova pilot per prevenir la sarcopènia ATDOM. Fundacio Mutuam Conviure. 2021IP:Laura Illamola Martin.

• Real World Burden of Chronic Kidney Disease A Population-Based Study In Catalonia, Northeast Spain. Boehringer Ingelheim España, S.A. 2023-2026. IP: Betlem Salvador Gonzalez.

• Prueba piloto de un programa de ejercicio para mejorar la calidad de vida y disminuir la sarcopenia en mujeres postmenopáusicas con osteoporosis. Sociedad Española de Medicos Generales y de Familia (SEMG). 2023-2026. IP: Laura Illamola Martin.

• Prognosis of CKD: a population-based epidemiological study. Bayer AG. 2019-2024. IP: Betlem Salvador Gonzalez.

• Ensayo clínico doble-ciego aleatorizado controlado con placebo para evaluar la eficacia en la sintomatología respiratoria leve-moderada de montelukast en pacientes con COVID persistente, PROYECTO E-SPERANZA COVID. Asociación ITWILLBE. 2021-2023. IP: Betlem Salvador Gonzalez.

• Efectividad de una intervención formativa para mejorar el abordaje de los pacientes con vértigo en atención primaria. Ensayo clínico VERTAP. (PI19/00736). Instituto de Salud Carlos III. 2019-2024. IP:  Luis Ballvé Moreno.

• Disseny i avaluació d'un programa d'atenció integral multidisciplinar en la Malaltia Renal Crònica Avançada (MaReCA). (SLT021/21/000031). Generalitat Catalunya. Departament de Salut. 2022IP:Iris Lumillo Gutierrez.

• Avaluació de l'impacte de l'obertura de l'oci nocturn - Reobrim Sitges. ICS - Institut Català de la Salut. 2021IP:Betlem Salvador Gonzalez.

• Avaluació de la massa muscular amb ecografia per l'abordatge precoç de la sarcopènia en adults majors inactius a l'atenció primària. 2023-2026. IP: Laura Illamola Martin.

• AVALUACIÓ DE LA MASSA MUSCULAR AMB ECOGRAFIA PER L'ABORDATGE PRECOÇ DE LA SARCOPÈNIA EN ADULTS MAJORS INACTIUS A L'ATENCIÓ PRIMÀRIA. 2023-2026. IP: Laura Illamola Martin.

• Avaluació de la inactivitat física i el risc de sarcopènia durant el dia mundial de l'activitat física en pacients d'atenció primària i població general. Estudi transversal. 2023-2023. IP: Laura Illamola Martin.

Group publications

JOURNAL PUBLICATIONS

• Koskela TH, Esteva M, Mangione M, Martos SC, Hajdarevic S, Högberg C et al. What would primary care practitioners do differently after a delayed cancer diagnosis? Learning lessons from their experiences. Scand. J. Prim. Health Care. 2023;42(1):123-131. PMID:38116949.

• Alemany A, Millat Martinez P, Corbacho Monné M, Suñer C, Galvan Casas C, Carrera C et al. Subcutaneous anti-COVID-19 hyperimmune immunoglobulin. EClinicalMedicine. 2023;57101898-101898. PMID:36936402.

• Ras Jiménez MD, Ramos Polo R, Manzano JF, Santano MC, Climent HM, Jose Bazán N et al. Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients. J Pers Med. 2023;13(8):PMID:37623532.

• Zabaleta Olmo E, Santesmases Masana R, Martín Payo R, Romero Collado A, Zamora Sánchez JJ, Urpí Fernández AM et al. Research on missed nursing care during the COVID-19 pandemic: A scoping review. Worldviews Evid.-Based Nurs. 2023;20(6):559-573. PMID:37743584.

• Rodoreda Pallàs B, Lumillo Gutiérrez I, Miró Catalina Q, Torra Escarrer E, Sanahuja Juncadella J, Morin Fraile V. Recording of Social Determinants in Computerized Medical Records in Primary Care Consultations: Quasi-Experimental Study. JMIR Form. Res. 2023;7PMID:36696168.

• Pedrazas Lopez D, de Pablo Marquez B, Cunillera Puertolas O, Almeda Ortega J, Invest RCParvulari GRP. RCParvulari training: A basic life support training methodology applied to 5-year-old students: Effectiveness in a cluster-randomized clinical trail. An. Pediatr. 2023;98(2):99-108. PMID:36740509.

• Aguilera CC, Vallespín EV, Escayola MC, Viladomat SY, Solana CF, Morte LA et al. Population-based evaluation of the impact of socioeconomic status on clinical outcomes in patients with heart failure in integrated care settings. Rev Esp Cardiol (Engl Ed). 2023;76(10):803-812. PMID:36963612.

• Rosello Novella A, Lumillo Gutierrez I, Pla Consuegra M, Rosa Castillo A, Villa Garcia L, Morin Fraile V. Percepciones y factores externos de la actividad f?sica en adolescentes mediante m?todos mixtos. Gac. Sanit. 2023;37

• de Homdedeu M, Sanchez Moral L, Violan C, Ràfols N, Ouchi D, Martín B et al. Mycobacterium manresensis induces trained immunity in vitro. iScience. 2023;26(6):106873-106873. PMID:37250788.

• Bundó D, Cunillera O, Arbiol Roca A, Cobo Guerrero S, Romano J, Gil Terron N et al. Final Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study. J Clin Med. 2023;12(14):PMID:37510717.

• Hajdarevic S, Högberg C, Marzo Castillejo M, Silina V, Sawicka Powierza J, Esteva M et al. Exploring why European primary care physicians sometimes do not think of, or act on, a possible cancer diagnosis. A qualitative study. BJGP Open. 2023;7(4):PMID:37380218.

• Vivó GT, Esquius NP, Puértolas OC, Riera MA, Albaladejo MI, Ballester LV. Description of thyroid disorders the year before conception: a population-based study. Front. Endocrinol. 2023;141236505-1236505. PMID:37818089.

• Ribera Osca JA, Carrion Valero F, Martin Gorgojo V, Rando Matos Y, Martin Cantera C, Martin Moreno JM. Characteristics of tobacco use among secondary school students: a cross-sectional study in a school in Valencia, Spain. Front. Public Health. 2023;111069294-1069294. PMID:37206875.

• Alcoberro L, Moliner P, Vime J, Jiménez Marrero S, Garay A, Yun S et al. Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure. PLoS One. 2023;18(2):-. PMID:36749763.

PROCEEDING PAPERS

• Peguero Rodriguez E, Perez Patiño J, Ballve JL, Villar I, Rando Y, Almeda J et al. Starting point for improving the approach to vertigo in primary care. Br. J. Gen. Pract. 2023;73PMID:37479255.

• Torres B, Morte L, Vela E, Cleries M, Corbella M, Jose N et al. Sex differences in medical resource use and outcomes in patients with heart failure in integrated care settings: Real-world evidence from population-based data of 77 554 patients. Eur. J. Heart Fail. 2023;25318-319.

• Torres B, Morte L, Vela E, Cleries M, Corbella M, Jose N et al. Influence of sex in the effectiveness of transitional-care heart failure programmes in patients with heart failure managed in integrated health care systems: A population-based study with longitudinal. Eur. J. Heart Fail. 2023;25319-319.

• Torres BB, Alcober L, Vela E, Cleries M, Corbella M, Jose N et al. Influence of age in the effectiveness of transitional-care heart failure programs in patients with heart failure managed in integrated health care systems: a population-based study with longitudinal r. Eur. J. Heart Fail. 2023;25230-231.

• Torres B, Alcober L, Vela E, Cleries M, Corbella M, Jose N et al. Impact of age in medical resource use and outcomes and temporal trends in patients with heart failure managed in a health system with universal coverage: a population-based analysis with real word dat. Eur. J. Heart Fail. 2023;25228-229.

• Morte LA, Torres B, Vela E, Cleries M, Corbella M, Jose N et al. Effectiveness of transitional-care programmes according to the sex of patients with heart failure managed in integrated care systems: a study with longitudinal real-world data in 77,554 patients. Eur. Heart J. 2023;44

TECHNICAL DOCUMENTS

• Mundet TuduriX, CegriF, SalvadorB, Segura AnducasA, Cobo GuerreroS, Vinyoles BargallóE et al. Consens català sobre atenció a la malaltia renal crònica (Consenso catalán sobre atención a la enfermedad renal crónica; Catalan consensus on chronic kidney disease care). 2023;